Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
					Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





1,3-Butadiene																				Related Pages
										May 1994
Immediately Dangerous to Life or Health Concentrations (IDLH)
**CAS number:** 106-99-0
**NIOSH REL:** None established; NIOSH considers 1,3-butadiene to be a potential occupational carcinogen as defined by the OSHA carcinogen policy [29 CFR 1990].
**Current OSHA PEL:** 1 ppm (2.2 mg/m3) TWA; 5 ppm (11.0 mg/m3) ST
**1989 OSHA PEL:** Same as current PEL
**1993-1994 ACGIH TLV:** 10 ppm (22 mg/m3) TWA, A2
**Description of Substance:** Colorless gas with a mild aromatic or gasoline-like odor.
**LEL:** 2.0% (10% LEL, 2,000 ppm)
**Original (SCP) IDLH:** 20,000 ppm [LEL]
**Basis for original (SCP) IDLH:** AIHA [1963] reported that narcosis did not occur in 2 humans inhaling 8,000 ppm during an 8-hour period [Carpenter et al. 1944]. AIHA [1963] also reported that inhalation of 6,700 ppm for 7.5 hours/day, 6 days/week for 8 months resulted in no significant chronic effects in rats, guinea pigs, rabbits, and dogs; some growth retardation and light cloudy swelling of livers did occur [Carpenter et al. 1944]. From the data given above, acutely toxic concentrations are obviously well above the lower explosive limit (LEL) of 20,000 ppm. For this draft technical standard, therefore, the LEL is used as the IDLH (i.e., the concentration above which only the “most protective” respirators are permitted).
**Existing short-term exposure:** 1991 American Industrial Hygiene Association guidelines (AIHA) Emergency Response Planning Guidelines
(ERPGs):
ERPG-1: 10 ppm (60-minute)
ERPG-2: 50 ppm (60-minute)
ERPG-3: 5,000 ppm (60-minute)
ACUTE TOXICITY DATA
**Lethal concentration data:**
AdjustedLC50
    LCLo
    
    0.5-hr
    DerivedSpecies
    Reference
    (ppm)
    (ppm)
    Time
    LC (CF)
    ValueRabbit
    Carpenter et al. 1944
    -----
    250,000
    30 min
    250,000 ppm(1.0)
    25,000 ppmMouse
    Dow 1941
    115,111
    -----
    ?
    ?
    ?Rat
    Dow 1941
    LC40: 200,000
    -----
    30 min
    200,000 ppm (1.0)
    20,000 ppmMouse
    Dow 1941
    122,000
    -----
    2 hr
    195,200 ppm (1.6)
    19,500 ppmRat
    Shugaev 1968
    126,667
    -----
    4 hr
    253,334 ppm (2.0)
    25,334 ppmRat
    Von Oettingen 1940
    130,000
    -----
    4 hr
    260,000 ppm (2.0)
    26,000 ppm**Other animal data:** Exposures to 6,700 ppm for 7.5 hours/day, 6 days/week for 8 months caused no progressive injury in rats, guinea pigs, rabbits, or 1 dog [Carpenter et al. 1944].
 **Human data:** Narcosis did not occur in volunteers exposed to 8,000 ppm for 8 hours [Carpenter et al. 1944]. Exposure to 10,000 ppm for 5 minutes has resulted in slight irritation and dryness of the nose and mouth with some increase in pulse rate but no effect on blood pressure or respiration [Shugaev 1968].
 **Revised IDLH:** 2,000 ppm [LEL]**Basis for revised IDLH:** Based on health considerations and acute inhalation toxicity data in humans [Carpenter et al. 1944; von Oettingen 1940] and animals [Carpenter et al. 1944; Dow 1941; Shugaev 1968; von Oettingen 1940], a value between 10,000 and 20,000 ppm would have been appropriate. However, the revised IDLH for 1,3-butadiene is 2,000 ppm based strictly on safety considerations (i.e., being 10% of the lower explosive limit of 2%). [Note: NIOSH recommends as part of its carcinogen policy that the "most protective" respirators be worn for 1,3-butadiene at any detectable concentration.]References:
AIHA [1963]. 1,3-Butadiene. In: Hygienic guide series. Am Ind Hyg Assoc J *2*4:91-92.
Carpenter CP, Shaffer CB, Weil CS, Smyth HF Jr [1944]. Studies on the inhalation of 1,3-butadiene; with a comparison of its narcotic effect with benzol, toluol, and styrene, and a note on the elimination of styrene by the human. J Ind Hyg Toxicol *26*(3):69-78.
Dow [1941]. Research report of inhalation toxicity of 1,3-butadiene. [Unpublished research]. Midland, MI: Dow Chemical Company. [From American Industrial Hygiene Association (AIHA) 1991 Emergency Response Planning Guidelines for 1,3-Butadiene.]
Shugaev BB [1968]. Distribution in the organism and toxicity of aliphatic hydrocarbons. Farmakol Toxsikol
31:162-165 (translated).
von Oettingen WR [1940]. Toxicity and potential dangers of aliphatic and aromatic hydrocarbons. A critical review of the literature. Public Health Bulletin 255:25.

			
							
								Page last reviewed:  December 4, 2014						Content
							source: 	National Institute for Occupational Safety and Health NIOSH Publications & Products
Immediately Dangerous To Life or Health (IDLH) Values
Table of IDLH Values
Criteria for Determining IDLH Values
Historical Documentation
Original (SCP) Values
Abbreviations for IDLH Documentation
Abbreviations for Journal Titles Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification/Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
					Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
					You will be subject to the destination website's privacy policy when you follow the link.
					CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue